Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High‐Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study.

Autor: Liang, Dong1 (AUTHOR), Li, Xiaojin2,3 (AUTHOR), Bai, Shenrui1 (AUTHOR), Wang, Qiaoli1 (AUTHOR), Zeng, Min1 (AUTHOR), Feng, Demei1 (AUTHOR), Lu, Bo4 (AUTHOR), Li, Xiaoqing5 (AUTHOR), Sun, Zhiqiang6 (AUTHOR), Li, Jianyun7 (AUTHOR), Zhou, Huanhuan8 (AUTHOR), Zhang, Jialu9 (AUTHOR), Chen, Xiaoqin1 (AUTHOR), Xia, Zhongjun1 (AUTHOR), Liang, Yang1 (AUTHOR) liangyang@sysucc.org.cn, Wang, Hua1 (AUTHOR) wanghua@sysucc.org.cn
Zdroj: Cancer Medicine. Oct2024, Vol. 13 Issue 20, p1-13. 13p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje